College of Chemistry and Materials Science, International Joint Laboratory on Resource Chemistry of Ministry Education, Shanghai Normal University, Shanghai 200234, P. R. China ...

Patients age 18 years or older from the United States and Canada with histologically confirmed stage IV or recurrent stage IIIB NSCLC per 7th International Association for the Study of Lung Cancer ...

with the more malignant tumor more commonly metastasizing to a separate primary benign or low-grade tumor. Lung carcinomas are the most common metastatic tumor donors.However, the opposite phenomenon ...

neutrophil-to-lymphocyte ratio (NLR), Pulmonary carcinoid, Survival & prognosis, non-small cell lung cancer (NSCLC), Serum C-reactive protein ...

When lung cancer advances after initial lines of therapy, the treatment options dwindle. An AbbVie drug gives patients a new choice as the first FDA-approved treatment for advanced cases of non ...

1Key Laboratory of Multi-Cell Systems, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, China. Search for ...

The imaging agent called Cytalux works by having patients receive an infusion before surgery that causes cancerous cells to glow like neon highlighter under infrared light. Qatar pushes back on ...

Table 1. Clinical Characteristics of Patients With NTRK-Rearranged Non–Small-Cell Lung Cancer Table 2. Molecular Characteristics of NTRK Rearrangements in Non–Small-Cell Lung Cancer Tumors Included in ...

Impaired T cell and neoantigen retention in time-serial analysis of metastatic non-small cell lung cancer in patients unresponsive to TIL cell therapy. Nature Cancer , 2025; DOI: 10.1038/s43018 ...